At least 10 countries in Europe have temporarily suspended the use of the British pharmaceutical company Astellicom’s Common Central Virus (COVID-19) vaccine (AZ vaccine) because of cases of blood clots after vaccination. Thailand has also announced a moratorium on the AZ vaccine.
The Thai Ministry of Public health held an emergency press conference this morning (March 12) to announce the postponement of the AZ vaccination program for Prime Minister Prayuth and members of his cabinet. The statement said that due to the suspected symptoms of blood clots after AZ vaccination in Denmark, although it is temporarily uncertain whether the symptoms are directly related to the vaccine, but to ensure the safety of the Thai people, the Ministry of Public Health decided to suspend the AZ vaccination program in Thailand, pending further evaluation results.
Italy is investigating the death of two men in Sicily after vaccination, and health authorities have ordered the withdrawal of a batch of AZ vaccine, Reuters reported, citing sources familiar with the matter.
Romania also said on the 11th that it had temporarily stopped using the same batch of the suspect vaccine as Italy for “extreme caution”, but would continue to use other batches of AZ vaccine.
Earlier on the 11th, the three Nordic countries of Denmark, Norway and Iceland announced the temporary suspension of the AZ vaccine, fearing that it could be linked to cases of blood clots.
Austria has also stopped using some batches of AZ vaccine after a 49-year-old caregiver died of “severe clotting problems” days after receiving the vaccine.
Subsequently, Estonia, Latvia, Lithuania and Luxembourg all stopped using the same batches of AZ vaccine as Austria.
According to the BBC, Italy and Austria stopped using different batches of the Chinese Communist virus vaccine.
The European Union Medicines Agency (EMA) said that there were 30 cases of blood clots among the 5 million people who had been vaccinated in Europe.
However, the EU Medicines Agency said on the 11th that “there is no indication that the vaccination caused these cases and they are not listed as side effects of this vaccine.” The EU Medicines Agency believes that the benefits of the CCP virus vaccine outweigh the risks and that it can continue to be administered while continuing to investigate cases of blood clots.
On the other hand, the U.K. said the AZ vaccine is “safe and effective,” and French Health Minister Olivier Veran said there is “no need” to stop using it.
Recent Comments